Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Respir Res

Retrieve available abstracts of 126 articles:
HTML format

Single Articles

    February 2024
  1. GAO J, Um-Bergstrom P, Pourbazargan M, Berggren-Brostrom E, et al
    Large airway T cells in adults with former bronchopulmonary dysplasia.
    Respir Res. 2024;25:86.
    PubMed     Abstract available

  2. LU T, Lahousse L, Wijnant S, Chen J, et al
    The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.
    Respir Res. 2024;25:85.
    PubMed     Abstract available

  3. WU W, Li J, Chen S, Ouyang S, et al
    The airway neuro-immune axis as a therapeutic target in allergic airway diseases.
    Respir Res. 2024;25:83.
    PubMed     Abstract available

  4. YU X, Li L, Cai B, Zhang W, et al
    Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma.
    Respir Res. 2024;25:76.
    PubMed     Abstract available

  5. CHANG YP, Tsai YH, Chen YM, Huang KT, et al
    Upregulated microRNA-125b-5p in patients with asthma-COPD overlap mediates oxidative stress and late apoptosis via targeting IL6R/TRIAP1 signaling.
    Respir Res. 2024;25:64.
    PubMed     Abstract available

    January 2024
  6. AUDOUSSET C, Swaleh S, Olivenstein R, Vameghestahbanati M, et al
    Mucus plugs in the airways of asthmatic subjects and smoking status.
    Respir Res. 2024;25:52.
    PubMed     Abstract available

  7. REUTER S, Raspe J, Taube C
    Microbes little helpers and suppliers for therapeutic asthma approaches.
    Respir Res. 2024;25:29.
    PubMed     Abstract available

  8. LI Z, Cheng T, Guo Y, Gao R, et al
    CD147 induces asthmatic airway remodeling and activation of circulating fibrocytes in a mouse model of asthma.
    Respir Res. 2024;25:6.
    PubMed     Abstract available

  9. DETSIKA MG, Palamaris K, Dimopoulou I, Kotanidou A, et al
    The complement cascade in lung injury and disease.
    Respir Res. 2024;25:20.
    PubMed     Abstract available

  10. PENG W, Xia Q, Zhang Y, Cao D, et al
    VEGF and EGFR signaling pathways are involved in the baicalein attenuation of OVA-induced airway inflammation and airway remodeling in mice.
    Respir Res. 2024;25:10.
    PubMed     Abstract available

    December 2023
  11. LOPEZ K, Li H, Lipkin-Moore Z, Kay S, et al
    Deep learning prediction of hospital readmissions for asthma and COPD.
    Respir Res. 2023;24:311.
    PubMed     Abstract available

  12. EL-HUSSEINI ZW, Khalenkow D, Lan A, van der Molen T, et al
    An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
    Respir Res. 2023;24:308.
    PubMed     Abstract available

  13. AKENROYE A, Nopsopon T, Cho L, Moll M, et al
    Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.
    Respir Res. 2023;24:305.
    PubMed     Abstract available

  14. HORVAT JC, Kim RY, Weaver N, Augood C, et al
    Characterization and inhibition of inflammasome responses in severe and non-severe asthma.
    Respir Res. 2023;24:303.
    PubMed     Abstract available

  15. HWANG H, Jang JH, Lee E, Park HS, et al
    Prediction of the number of asthma patients using environmental factors based on deep learning algorithms.
    Respir Res. 2023;24:302.
    PubMed     Abstract available

    November 2023
  16. CHEN B, Liu Z, Lu J, Li Z, et al
    Deep learning parametric response mapping from inspiratory chest CT scans: a new approach for small airway disease screening.
    Respir Res. 2023;24:299.
    PubMed     Abstract available

  17. GAGNON PA, Klein M, De Vos J, Biardel S, et al
    S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty.
    Respir Res. 2023;24:294.
    PubMed     Abstract available

  18. VAN DER SAR IG, Wijsenbeek MS, Braunstahl GJ, Loekabino JO, et al
    Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    Respir Res. 2023;24:271.
    PubMed     Abstract available

  19. TEE JH, Vijayakumar U, Shanmugasundaram M, Lam TYW, et al
    Isthmin-1 attenuates allergic Asthma by stimulating adiponectin expression and alveolar macrophage efferocytosis in mice.
    Respir Res. 2023;24:269.
    PubMed     Abstract available

    October 2023
  20. HEMPEL P, Klein V, Michely A, Boll S, et al
    Amitriptyline inhibits bronchoconstriction and directly promotes dilatation of the airways.
    Respir Res. 2023;24:262.
    PubMed     Abstract available

  21. CHANG C, Chen G, Wu W, Chen D, et al
    Exogenous IL-25 ameliorates airway neutrophilia via suppressing macrophage M1 polarization and the expression of IL-12 and IL-23 in asthma.
    Respir Res. 2023;24:260.
    PubMed     Abstract available

  22. LIU L, Zhou L, Wang L, Mao Z, et al
    MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-kappaB pathway.
    Respir Res. 2023;24:255.
    PubMed     Abstract available

  23. YASUDA Y, Wang L, Chitano P, Seow CY, et al
    Critical roles of airway smooth muscle in mediating deep-inspiration-induced bronchodilation: a big stretch?
    Respir Res. 2023;24:250.
    PubMed     Abstract available

    September 2023
  24. SPECTOR C, De Sanctis CM, Panettieri RA Jr, Koziol-White CJ, et al
    Rhinovirus induces airway remodeling: what are the physiological consequences?
    Respir Res. 2023;24:238.
    PubMed     Abstract available

  25. PADILLA-GALO A, Moya Carmona I, Ausin P, Carazo Fernandez L, et al
    Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.
    Respir Res. 2023;24:235.
    PubMed     Abstract available

  26. SHEN K, Zhang M, Zhao R, Li Y, et al
    Eosinophil extracellular traps in asthma: implications for pathogenesis and therapy.
    Respir Res. 2023;24:231.
    PubMed     Abstract available

  27. KARAKIOULAKI M, Berkemeier CM, Heijnen I, Grize L, et al
    Staphylococcus aureus enterotoxin A- and B-specific IgE in chronic obstructive pulmonary disease.
    Respir Res. 2023;24:225.
    PubMed     Abstract available

  28. DEY S, Lu W, Haug G, Chia C, et al
    Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study.
    Respir Res. 2023;24:221.
    PubMed     Abstract available

  29. LIU J, Chen Y, Chen H, Wang Y, et al
    Macrophage migration inhibitory factor exacerbates asthmatic airway remodeling via dynamin-related protein 1-mediated autophagy activation.
    Respir Res. 2023;24:216.
    PubMed     Abstract available

    August 2023
  30. YAO X, Chen Q, Wang X, Liu X, et al
    IL-25 induces airway remodeling in asthma by orchestrating the phenotypic changes of epithelial cell and fibrocyte.
    Respir Res. 2023;24:212.
    PubMed     Abstract available

  31. TAKEUCHI H, Hasan SMT, Zaman K, Takanashi S, et al
    Correction to: Impact of Haemophilus influenzae type b combination vaccination on asthma symptoms and pneumonia in 5-year-old children in rural Bangladesh: a longitudinal study and comparison with a previous cross-sectional study.
    Respir Res. 2023;24:210.

  32. DY ABC, Girkin J, Marrocco A, Collison A, et al
    Rhinovirus infection induces secretion of endothelin-1 from airway epithelial cells in both in vitro and in vivo models.
    Respir Res. 2023;24:205.
    PubMed     Abstract available

  33. BURBANK AJ, Atkinson CE, Espaillat AE, Schworer SA, et al
    Race-specific spirometry equations may overestimate asthma control in Black children and adolescents.
    Respir Res. 2023;24:203.
    PubMed     Abstract available

  34. KRAMER EL, Hudock KM, Davidson CR, Clancy JP, et al
    CFTR dysfunction in smooth muscle drives TGFbeta dependent airway hyperreactivity.
    Respir Res. 2023;24:198.
    PubMed     Abstract available

    July 2023
  35. JONES AC, Leffler J, Laing IA, Bizzintino J, et al
    LPS binding protein and activation signatures are upregulated during asthma exacerbations in children.
    Respir Res. 2023;24:184.
    PubMed     Abstract available

  36. STRULOVICI-BAREL Y, Kaner RJ, Crystal RG
    High apoptotic endothelial microparticle levels measured in asthma with elevated IgE and eosinophils.
    Respir Res. 2023;24:180.
    PubMed     Abstract available

  37. RASPE J, Schmitz MS, Barbet K, Caso GC, et al
    Therapeutic properties of Helicobacter pylori-derived vacuolating cytotoxin A in an animal model of chronic allergic airway disease.
    Respir Res. 2023;24:178.
    PubMed     Abstract available

    June 2023
  38. HAKANSSON KEJ, Guerrero SC, Backer V, Ulrik CS, et al
    Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort.
    Respir Res. 2023;24:173.
    PubMed     Abstract available

  39. WANG Z, Li Y, Gao Y, Fu Y, et al
    Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Respir Res. 2023;24:169.
    PubMed     Abstract available

  40. WANG Z, He Y, Li Q, Zhao Y, et al
    Dysregulation of iron homeostasis in airways associated with persistent preschool wheezing.
    Respir Res. 2023;24:170.
    PubMed     Abstract available

  41. AHN SY, Lee J, Lee DH, Ho TL, et al
    Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice.
    Respir Res. 2023;24:160.
    PubMed     Abstract available

  42. DONOGHUE LJ, McFadden KM, Vargas D, Smith GJ, et al
    Collaborative cross strain CC011/UncJ as a novel mouse model of T2-high, severe asthma.
    Respir Res. 2023;24:153.
    PubMed     Abstract available

  43. ROGNONI C, Milano C, Heffler E, Bonini M, et al
    Economic impact of a more extensive use of FENO testing on the Italian population with asthma.
    Respir Res. 2023;24:147.
    PubMed     Abstract available

    May 2023
  44. KANJ AN, Kottom TJ, Schaefbauer KJ, Choudhury M, et al
    Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans.
    Respir Res. 2023;24:144.
    PubMed     Abstract available

  45. VULTAGGIO A, Aliani M, Altieri E, Bracciale P, et al
    Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
    Respir Res. 2023;24:135.
    PubMed     Abstract available

  46. GENOFRE E, Carstens D, DeBacker W, Muchmore P, et al
    The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach.
    Respir Res. 2023;24:121.
    PubMed     Abstract available

  47. CHEN W, Reddel HK, FitzGerald JM, Beasley R, et al
    Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials.
    Respir Res. 2023;24:120.
    PubMed     Abstract available

    April 2023
  48. TOMASZEWSKI EL, Atkinson MJ, Janson C, Karlsson N, et al
    Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
    Respir Res. 2023;24:106.
    PubMed     Abstract available

  49. LI J, Zheng Z, Liu Y, Zhang H, et al
    IRAK-M has effects in regulation of lung epithelial inflammation.
    Respir Res. 2023;24:103.
    PubMed     Abstract available

    March 2023
  50. HE LX, Yang L, Liu T, Li YN, et al
    Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
    Respir Res. 2023;24:90.
    PubMed     Abstract available

  51. CHOI YJ, Han H, Lee JH, Lee J, et al
    Particulate matter(10)-induced airway inflammation and fibrosis can be regulated by chitinase-1 suppression.
    Respir Res. 2023;24:85.
    PubMed     Abstract available

  52. TALAEI M, Emmett PM, Granell R, Tabatabaeian H, et al
    Dietary patterns, lung function and asthma in childhood: a longitudinal study.
    Respir Res. 2023;24:82.
    PubMed     Abstract available

  53. HEIDARI-FOROOZAN M, Aryan A, Esfahani Z, Shahrbaf MA, et al
    National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
    Respir Res. 2023;24:74.
    PubMed     Abstract available

  54. HORTON DB, Neikirk AL, Yang Y, Huang C, et al
    Childhood asthma diagnoses declined during the COVID-19 pandemic in the United States.
    Respir Res. 2023;24:72.
    PubMed     Abstract available

  55. FAVERIO P, Ronco R, Monzio Compagnoni M, Franchi M, et al
    Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study.
    Respir Res. 2023;24:70.
    PubMed     Abstract available

    February 2023
  56. WANG XW, Wang T, Schaub DP, Chen C, et al
    Benchmarking omics-based prediction of asthma development in children.
    Respir Res. 2023;24:63.
    PubMed     Abstract available

  57. LIN X, Wang L, Lu X, Zhang Y, et al
    Targeting of G-protein coupled receptor 40 alleviates airway hyperresponsiveness through RhoA/ROCK1 signaling pathway in obese asthmatic mice.
    Respir Res. 2023;24:56.
    PubMed     Abstract available

  58. KWOK WC, Tam TCC, Lam DCL, Leung JKC, et al
    Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong.
    Respir Res. 2023;24:53.
    PubMed     Abstract available

  59. XU X, Zheng F, Xu S, Hu M, et al
    Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.
    Respir Res. 2023;24:50.
    PubMed     Abstract available

    January 2023
  60. SAFONOVA E, Yawn BP, Welte T, Wang C, et al
    Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
    Respir Res. 2023;24:35.
    PubMed     Abstract available

  61. TU X, Gomez HM, Kim RY, Brown AC, et al
    Airway and parenchyma transcriptomics in a house dust mite model of experimental asthma.
    Respir Res. 2023;24:32.
    PubMed     Abstract available

  62. GARCIA-GARCIA ML, Sastre B, Arroyas M, Beato M, et al
    Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age.
    Respir Res. 2023;24:26.
    PubMed     Abstract available

  63. SPRINGVLOET L, Triemstra M, Knottnerus B, Rolink M, et al
    Validation of the CaReQoL asthma: a patient reported outcome measure for monitoring the perceived effects of pulmonary rehabilitation in adult patients with severe refractory asthma.
    Respir Res. 2023;24:14.
    PubMed     Abstract available

  64. GOULD GS, Hurst JR, Trofor A, Alison JA, et al
    Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group).
    Respir Res. 2023;24:15.
    PubMed     Abstract available

  65. QURAISHI E, Jibuaku C, Lisik D, Wennergren G, et al
    Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden.
    Respir Res. 2023;24:10.
    PubMed     Abstract available

  66. ZHOU Z, Liang S, Zhou Z, Liu J, et al
    TGF-beta1 promotes SCD1 expression via the PI3K-Akt-mTOR-SREBP1 signaling pathway in lung fibroblasts.
    Respir Res. 2023;24:8.
    PubMed     Abstract available

  67. BANDEIRA E, Jang SC, Lasser C, Johansson K, et al
    Effects of mesenchymal stem cell-derived nanovesicles in experimental allergic airway inflammation.
    Respir Res. 2023;24:3.
    PubMed     Abstract available

    December 2022
  68. CHENG WH, Kao SY, Chen CL, Yuliani FS, et al
    Amphiregulin induces CCN2 and fibronectin expression by TGF-beta through EGFR-dependent pathway in lung epithelial cells.
    Respir Res. 2022;23:381.
    PubMed     Abstract available

  69. CAY P, Singer CA, Ba MA
    Gene network analysis for identification of microRNA biomarkers for asthma.
    Respir Res. 2022;23:378.
    PubMed     Abstract available

  70. AMEGADZIE JE, Gamble JM, Farrell J, Gao Z, et al
    Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled beta2-agonists in patients with asthma, COPD or asthma-COPD overlap.
    Respir Res. 2022;23:364.
    PubMed     Abstract available

  71. NOMURA N, Matsumoto H, Yokoyama A, Nishimura Y, et al
    Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes.
    Respir Res. 2022;23:365.
    PubMed     Abstract available

  72. POURESLAMI I, FitzGerald JM, Tregobov N, Goldstein RS, et al
    Health literacy in asthma and chronic obstructive pulmonary disease (COPD) care: a narrative review and future directions.
    Respir Res. 2022;23:361.
    PubMed     Abstract available

  73. GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
    Correction to: CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
    Respir Res. 2022;23:350.

  74. DUPONT A, Couffignal C, Arias C, Salah K, et al
    Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients.
    Respir Res. 2022;23:342.
    PubMed     Abstract available

  75. STUBBS MA, Clark VL, Gibson PG, Yorke J, et al
    Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma.
    Respir Res. 2022;23:341.
    PubMed     Abstract available

  76. ELLER MCN, Pierantozzi Vergani K, Saraiva-Romanholo BM, de Souza Xavier Costa N, et al
    Bronchial eosinophils, neutrophils, and CD8 + T cells influence asthma control and lung function in schoolchildren and adolescents with severe treatment-resistant asthma.
    Respir Res. 2022;23:335.
    PubMed     Abstract available

    November 2022
  77. MA L, Zhu M, Li G, Gai J, et al
    Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
    Respir Res. 2022;23:316.
    PubMed     Abstract available

  78. GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
    CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
    Respir Res. 2022;23:305.
    PubMed     Abstract available

    October 2022
  79. XIA M, Xu F, Ni H, Wang Q, et al
    Neutrophil activation and NETosis are the predominant drivers of airway inflammation in an OVA/CFA/LPS induced murine model.
    Respir Res. 2022;23:289.
    PubMed     Abstract available

  80. RAO X, Dong H, Zhang W, Sun H, et al
    MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1.
    Respir Res. 2022;23:286.
    PubMed     Abstract available

  81. YI F, Zhan C, Liu B, Li H, et al
    Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
    Respir Res. 2022;23:279.
    PubMed     Abstract available

    September 2022
  82. FALLAHZADEH A, Sharifnejad Tehrani Y, Sheikhy A, Ghamari SH, et al
    The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.
    Respir Res. 2022;23:268.
    PubMed     Abstract available

  83. XU J, Sun X, Zhu H, Cao Y, et al
    Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma.
    Respir Res. 2022;23:262.
    PubMed     Abstract available

  84. DALEY-YATES P, Keppler B, Baines A, Bardsley G, et al
    Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
    Respir Res. 2022;23:258.
    PubMed     Abstract available

  85. MAGWENZI P, Rusakaniko S, Sibanda EN, Gumbo FZ, et al
    Challenges in the diagnosis of asthma in children, what are the solutions? A scoping review of 3 countries in sub Saharan Africa.
    Respir Res. 2022;23:254.
    PubMed     Abstract available

  86. LIU Y, Shi G
    Roles of sirtuins in asthma.
    Respir Res. 2022;23:251.
    PubMed     Abstract available

  87. LEUNG C, Ryu MH, Bolling AK, Maestre-Batlle D, et al
    Peroxisome proliferator-activated receptor gamma gene variants modify human airway and systemic responses to indoor dibutyl phthalate exposure.
    Respir Res. 2022;23:248.
    PubMed     Abstract available

  88. FENG KN, Meng P, Zou XL, Zhang M, et al
    IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma.
    Respir Res. 2022;23:244.
    PubMed     Abstract available

  89. ZHOU J, Yi F, Wu F, Xu P, et al
    Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China.
    Respir Res. 2022;23:243.
    PubMed     Abstract available

  90. LEE HW, Baek MG, Choi S, Ahn YH, et al
    Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.
    Respir Res. 2022;23:237.
    PubMed     Abstract available

  91. ALTHOFF MD, Jimenez G, Peterson R, Jin Y, et al
    Differences in L-arginine metabolism and asthma morbidity among asthma patients with and without obstructive sleep apnea.
    Respir Res. 2022;23:230.
    PubMed     Abstract available

    August 2022
  92. ROGLIANI P, Cavalli F, Ritondo BL, Cazzola M, et al
    Sex differences in adult asthma and COPD therapy: a systematic review.
    Respir Res. 2022;23:222.
    PubMed     Abstract available

    July 2022
  93. BODUM KS, Hjerrild BE, Dalsgaard S, Rubak SLM, et al
    Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma.
    Respir Res. 2022;23:192.
    PubMed     Abstract available

  94. KAN M, Sun M, Jiang X, Diwadkar AR, et al
    CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
    Respir Res. 2022;23:193.
    PubMed     Abstract available

  95. RIEG AD, Suleiman S, Anker C, Bunting NA, et al
    Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation.
    Respir Res. 2022;23:189.
    PubMed     Abstract available

  96. CHEN CH, Wu CD, Lee YL, Lee KY, et al
    Air pollution enhance the progression of restrictive lung function impairment and diffusion capacity reduction: an elderly cohort study.
    Respir Res. 2022;23:186.
    PubMed     Abstract available

  97. BIGNOLD R, Shammout B, Rowley JE, Repici M, et al
    Chemokine CXCL12 drives pericyte accumulation and airway remodeling in allergic airway disease.
    Respir Res. 2022;23:183.
    PubMed     Abstract available

    June 2022
  98. GOUDARZI H, Kimura H, Kimura H, Makita H, et al
    Effects of obesity on CC16 and their potential role in overweight/obese asthma.
    Respir Res. 2022;23:174.
    PubMed     Abstract available

  99. LE NPK, do Nascimento AF, Schneberger D, Quach CC, et al
    Deficiency of leukocyte-specific protein 1 (LSP1) alleviates asthmatic inflammation in a mouse model.
    Respir Res. 2022;23:165.
    PubMed     Abstract available

    May 2022
  100. IHRIE MD, McQuade VL, Womble JT, Hegde A, et al
    Exogenous leptin enhances markers of airway fibrosis in a mouse model of chronic allergic airways disease.
    Respir Res. 2022;23:131.
    PubMed     Abstract available

  101. JACKSON D, Walum J, Banerjee P, Lewis BW, et al
    Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle.
    Respir Res. 2022;23:126.
    PubMed     Abstract available

  102. HUANG K, Li F, Wang X, Yan B, et al
    Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: a cross-sectional study.
    Respir Res. 2022;23:119.
    PubMed     Abstract available

  103. LIU Y, Qu HQ, Qu J, Chang X, et al
    Burden of rare coding variants reveals genetic heterogeneity between obese and non-obese asthma patients in the African American population.
    Respir Res. 2022;23:116.
    PubMed     Abstract available

    April 2022
  104. LI R, Chen Y, Zhao A, Huang L, et al
    Exploring genetic association of insomnia with allergic disease and asthma: a bidirectional Mendelian randomization study.
    Respir Res. 2022;23:84.
    PubMed     Abstract available

    March 2022
  105. YU C, Huang W, Zhou Z, Liang S, et al
    Short isoform thymic stromal lymphopoietin reduces inflammation and aerobic glycolysis of asthmatic airway epithelium by antagonizing long isoform thymic stromal lymphopoietin.
    Respir Res. 2022;23:75.
    PubMed     Abstract available

  106. HOFFMANN C, Maglakelidze M, von Schneidemesser E, Witt C, et al
    Asthma and COPD exacerbation in relation to outdoor air pollution in the metropolitan area of Berlin, Germany.
    Respir Res. 2022;23:64.
    PubMed     Abstract available

  107. WEITOFT M, Kadefors M, Stenberg H, Tufvesson E, et al
    Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics.
    Respir Res. 2022;23:50.
    PubMed     Abstract available

  108. KORN S, Howarth P, Smith SG, Price RG, et al
    Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
    Respir Res. 2022;23:45.
    PubMed     Abstract available

    February 2022
  109. CHEN Y, Kong D, Fu J, Zhang Y, et al
    Associations between ambient temperature and adult asthma hospitalizations in Beijing, China: a time-stratified case-crossover study.
    Respir Res. 2022;23:38.
    PubMed     Abstract available

  110. MENZELLA F, Bargagli E, Aliani M, Bracciale P, et al
    ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
    Respir Res. 2022;23:36.
    PubMed     Abstract available

  111. SCHAUNAMAN N, Dimasuay KG, Kraft M, Chu HW, et al
    Tollip interaction with STAT3: a novel mechanism to regulate human airway epithelial responses to type 2 cytokines.
    Respir Res. 2022;23:31.
    PubMed     Abstract available

    January 2022
  112. WU W, Gao J, Chen D, Chen G, et al
    Epithelial microRNA-30a-3p targets RUNX2/HMGB1 axis to suppress airway eosinophilic inflammation in asthma.
    Respir Res. 2022;23:17.
    PubMed     Abstract available

    December 2021
  113. SKIBBA ME, Xu X, Weiss K, Huisken J, et al
    Role of Secretoglobin(+) (club cell) NFkappaB/RelA-TGFbeta signaling in aero-allergen-induced epithelial plasticity and subepithelial myofibroblast transdifferentiation.
    Respir Res. 2021;22:315.
    PubMed     Abstract available

  114. MASPERO J, Agache IO, Kamei T, Yoshida M, et al
    Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.
    Respir Res. 2021;22:311.
    PubMed     Abstract available

  115. BURBANK AJ, Schworer SA, Sood A, Almond M, et al
    Airway IL-1beta associates with IL-5 production following dust mite allergen inhalation in humans.
    Respir Res. 2021;22:309.
    PubMed     Abstract available

    November 2021
  116. KOSHY K, Sha J, Bennetts K, Langton D, et al
    Safety of delivering bronchial thermoplasty in two treatment sessions.
    Respir Res. 2021;22:307.
    PubMed     Abstract available

  117. SVERRILD A, Leadbetter J, Porsbjerg C
    The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations.
    Respir Res. 2021;22:287.
    PubMed     Abstract available

    October 2021
  118. HARDING JN, Gross M, Patel V, Potter S, et al
    Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
    Respir Res. 2021;22:275.
    PubMed     Abstract available

  119. TUPPER OD, Ulrik CS
    Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
    Respir Res. 2021;22:269.
    PubMed     Abstract available

  120. CARSTENSEN S, Gress C, Erpenbeck VJ, Kazani SD, et al
    Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor.
    Respir Res. 2021;22:262.
    PubMed     Abstract available

    August 2021
  121. ZHANG S, Fan Y, Qin L, Fang X, et al
    IL-1beta augments TGF-beta inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics.
    Respir Res. 2021;22:216.
    PubMed     Abstract available

    April 2021
  122. HEALY C, Munoz-Wolf N, Strydom J, Faherty L, et al
    Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.
    Respir Res. 2021;22:133.
    PubMed     Abstract available

    February 2021
  123. LI LY, Yan TS, Yang J, Li YQ, et al
    Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function.
    Respir Res. 2021;22:68.
    PubMed     Abstract available

  124. SAITO T, Ichikawa T, Numakura T, Yamada M, et al
    PGC-1alpha regulates airway epithelial barrier dysfunction induced by house dust mite.
    Respir Res. 2021;22:63.
    PubMed     Abstract available

  125. VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
    The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
    Respir Res. 2021;22:48.
    PubMed     Abstract available

  126. WANG Y, Liao K, Liu B, Niu C, et al
    GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
    Respir Res. 2021;22:46.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.